UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
Under the Securities Exchange Act of 1934
 
(Amendment No. 3)*
 
 
BioSpecifics Technologies Corp.
(Name of Issuer)
 
Common Stock, $0.001 par value
(Title of Class of Securities)
 
090931106
(CUSIP Number)
 
December 31, 2016
Date of Event Which Requires Filing of this Statement
 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[   ]  Rule 13d-1(b)
 
[X]  Rule 13d-1(c)
 
[   ]  Rule 13d-1(d)

*  The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
 
 

 
CUSIP No. 090931106
 


1
Name of Reporting Person:
Abdiel Qualified Master Fund LP
 
I.R.S. Identification No. of above Person (entities only) (voluntary)
 
 
2
Check the Appropriate Box if a Member of a Group
 
(a)  [   ]
(b)  [   ]
 
 
3
SEC USE ONLY
 
 
 
4
Citizenship or Place of Organization

Cayman Islands
 
 


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
 
6
SHARED VOTING POWER
0
 
7
SOLE  DISPOSITIVE POWER
0
 
8
SHARED DISPOSITIVE POWER
0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED
0
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0
 
12
TYPE OF REPORTING PERSON
PN
 
 
 
 
 
2

 
CUSIP No. 090931106

 

1
Names of Reporting Person:
Abdiel Capital LP
 
I.R.S. Identification No. of above Person (entities only) (voluntary)
 
 
2
Check the Appropriate Box if a Member of a Group
 
(a)  [   ]
(b)  [   ]
 
 
3
SEC USE ONLY
 
 
 
4
Citizenship or Place of Organization

Delaware
 
 


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
 
6
SHARED VOTING POWER
0
 
7
SOLE  DISPOSITIVE POWER
0
 
8
SHARED DISPOSITIVE POWER
0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED
0
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0
 
12
TYPE OF REPORTING PERSON
PN
 
 
 
 
3

 
CUSIP No. 090931106
 


1
Names of Reporting Person:
Abdiel Capital Management, LLC
 
I.R.S. Identification No. of above Person (entities only) (voluntary)
 
 
2
Check the Appropriate Box if a Member of a Group
 
(a)  [   ]
(b)  [   ]
 
 
3
SEC USE ONLY
 
 
 
4
Citizenship or Place of Organization

Delaware
 
 


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
 
6
SHARED VOTING POWER
0
 
7
SOLE  DISPOSITIVE POWER
0
 
8
SHARED DISPOSITIVE POWER
0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED
0
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0
 
12
TYPE OF REPORTING PERSON
OO
 
 
 
 
4

 
CUSIP No. 090931106

 

1
Names of Reporting Person:
Abdiel Capital Advisors, LP
 
I.R.S. Identification No. of above Person (entities only) (voluntary)
 
 
2
Check the Appropriate Box if a Member of a Group
 
(a)  [   ]
(b)  [   ]
 
 
3
SEC USE ONLY
 
 
 
4
Citizenship or Place of Organization

Delaware
 
 


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
 
6
SHARED VOTING POWER
0
 
7
SOLE  DISPOSITIVE POWER
0
 
8
SHARED DISPOSITIVE POWER
0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED
0
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0
 
12
TYPE OF REPORTING PERSON
PN, IA
 

 
 
 
 
5

 
CUSIP No. 090931106
 
 

1
Names of Reporting Person:
Colin T. Moran
 
I.R.S. Identification No. of above Person (entities only) (voluntary)
 
 
2
Check the Appropriate Box if a Member of a Group
 
(a)  [   ]
(b)  [   ]
 
 
3
SEC USE ONLY
 
 
 
4
Citizenship or Place of Organization

United States
 
 


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
 
6
SHARED VOTING POWER
0
 
7
SOLE  DISPOSITIVE POWER
0
 
8
SHARED DISPOSITIVE POWER
0
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED
0
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0
 
12
TYPE OF REPORTING PERSON
IN
 

 

 
6

 
CUSIP No. 090931106

 
SCHEDULE 13G AMENDMENT NO. 3 (FINAL AMENDMENT)

 
Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on December 19, 2014, Amendment No. 1 thereto filed on February 11, 2015 and Amendment No. 2 thereto filed on February 11, 2016   (as so amended, the "Schedule 13G").  Terms defined in the Schedule 13G are used herein as so defined.
The following Items of the Schedule 13G are hereby amended and restated as follows:
Item 4
Ownership:
 
(a) through (c):
 
The information requested herein is incorporated by reference to the cover pages to this Amendment No. 3 to Schedule 13G .
 
Abdiel Capital Management, LLC and Abdiel Capital Advisors, LP serve as the general partner and the investment manager, respectively, of Abdiel Qualified Master Fund LP and Abdiel Capital LP.  Colin T. Moran serves as managing member of  Abdiel Capital Management, LLC and Abdiel Capital Partners, LLC, which serves as the general partner of Abdiel Capital Advisors, LP.  Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
   
Item 5
Ownership of Five Percent or Less of a Class:
 
If this statement is being filed to report the fact that the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following:   [ X ]
 

 
 

 
7

 
CUSIP No. 090931106

 
SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:  January 24, 2017

 
ABDIEL QUALIFIED MASTER FUND LP
 
 
By:
Abdiel Capital Management, LLC,
its General Partner
 
 
By:
/s/ Colin T. Moran
   
Colin T. Moran, Managing Member
 
 
 
ABDIEL CAPITAL LP
 
 
By:
Abdiel Capital Management, LLC,
its General Partner
 
 
By:
/s/ Colin T. Moran
   
Colin T. Moran, Managing Member
 
 
 
ABDIEL CAPITAL MANAGEMENT, LLC
 
 
By:
/s/ Colin T. Moran
   
Colin T. Moran, Managing Member
 
 
 
ABDIEL CAPITAL ADVISORS, LP
 
 
By:
Abdiel Capital Partners, LLC,
its General Partner
 
 
By:
/s/ Colin T. Moran
   
Colin T. Moran, Managing Member
 
 
 
COLIN T. MORAN
 
 
By:
/s/ Colin T. Moran
   
Colin T. Moran, Individually
 
 
 
 
 
8

BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BioSpecifics Technologies Charts.
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BioSpecifics Technologies Charts.